HCSGD entry for EPO
1. General information
Official gene symbol | EPO |
---|---|
Entrez ID | 2056 |
Gene full name | erythropoietin |
Other gene symbols | EP MVCD2 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0005128 | Erythropoietin receptor binding | IEA | molecular_function |
GO:0005179 | Hormone activity | IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005576 | Extracellular region | TAS | cellular_component |
GO:0005615 | Extracellular space | IDA | cellular_component |
GO:0006915 | Apoptotic process | IEA | biological_process |
GO:0007165 | Signal transduction | NAS | biological_process |
GO:0007566 | Embryo implantation | IEA | biological_process |
GO:0007568 | Aging | IEA | biological_process |
GO:0008015 | Blood circulation | NAS | biological_process |
GO:0008284 | Positive regulation of cell proliferation | IDA | biological_process |
GO:0009651 | Response to salt stress | IEA | biological_process |
GO:0009986 | Cell surface | IDA | cellular_component |
GO:0010523 | Negative regulation of calcium ion transport into cytosol | IDA | biological_process |
GO:0018105 | Peptidyl-serine phosphorylation | IEA | biological_process |
GO:0030295 | Protein kinase activator activity | IEA | molecular_function |
GO:0032496 | Response to lipopolysaccharide | IEA | biological_process |
GO:0033189 | Response to vitamin A | IEA | biological_process |
GO:0033574 | Response to testosterone | IEA | biological_process |
GO:0042523 | Positive regulation of tyrosine phosphorylation of Stat5 protein | IDA | biological_process |
GO:0042541 | Hemoglobin biosynthetic process | IEA | biological_process |
GO:0043249 | Erythrocyte maturation | IEA | biological_process |
GO:0043627 | Response to estrogen | IEA | biological_process |
GO:0045666 | Positive regulation of neuron differentiation | IEA | biological_process |
GO:0045740 | Positive regulation of DNA replication | IDA | biological_process |
GO:0045893 | Positive regulation of transcription, DNA-templated | IDA | biological_process |
GO:0046579 | Positive regulation of Ras protein signal transduction | IDA | biological_process |
GO:0048678 | Response to axon injury | IEA | biological_process |
GO:0051602 | Response to electrical stimulus | IEA | biological_process |
GO:0055093 | Response to hyperoxia | IEA | biological_process |
GO:0061418 | Regulation of transcription from RNA polymerase II promoter in response to hypoxia | TAS | biological_process |
GO:0070555 | Response to interleukin-1 | IEA | biological_process |
GO:0071456 | Cellular response to hypoxia | TAS | biological_process |
GO:0071474 | Cellular hyperosmotic response | IDA | biological_process |
GO:1902219 | Negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | IDA | biological_process |
GO:1902251 | Negative regulation of erythrocyte apoptotic process | IDA | biological_process |
GO:2001258 | Negative regulation of cation channel activity | IDA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.4280411762 | 0.9055762965 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0668141190 |
GSE13712_SHEAR | Down | -0.1890092304 |
GSE13712_STATIC | Up | 0.0509073430 |
GSE19018 | Up | 0.1359787536 |
GSE19899_A1 | Down | -0.0931834105 |
GSE19899_A2 | Up | 0.1634866546 |
PubMed_21979375_A1 | Up | 0.1896890342 |
PubMed_21979375_A2 | Up | 0.0106203264 |
GSE35957 | Up | 0.0443052503 |
GSE36640 | Up | 0.1309402046 |
GSE54402 | Up | 0.0633205662 |
GSE9593 | Down | -0.0645939563 |
GSE43922 | Up | 0.1647119205 |
GSE24585 | Up | 0.0512264200 |
GSE37065 | Down | -0.0838864179 |
GSE28863_A1 | Down | -0.1090150241 |
GSE28863_A2 | Up | 0.2066355622 |
GSE28863_A3 | Up | 0.4206029539 |
GSE28863_A4 | Up | 0.0403805914 |
GSE48662 | Up | 0.0948877258 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
No target information from mirTarBase
- mirTarBase
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 10 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
26610640 | Erythropoietin preconditioning improves clinical and histologic outcome in an acute spinal cord ischemia and reperfusion rabbit model |
26610640 | OBJECTIVE: This study examined effects and functional outcome of recombinant human erythropoietin (rhEPO) and carbamylated erythropoietin fusion protein (cEPO-FC) preconditioning in a rabbit model for spinal cord ischemia and resulting paraplegia |
24592241 | Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO) |
24592241 | Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO) |
24592241 | EPO plasma levels then decline and a decrease in RBC mass takes place, apparently because of the selective lysis of the youngest, recently generated RBCs (neocytes) |
24592241 | After descent, the polycythaemia developed at high altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs |
24592241 | In vivo, neocytolysis seems to be abolished by EPO administration |
24592241 | Why neocytes are specifically destroyed and how is this related to decreased EPO levels has not yet been elucidated |
19782086 | Erythropoietin (EPO) prevents cell apoptosis induced by oxidative stress |
19782086 | Carbamylated EPO maintains the tissue-protective activities of the unmodified EPO but does not stimulate erythropoiesis |
19782086 | Carbamylated EPO maintains the tissue-protective activities of the unmodified EPO but does not stimulate erythropoiesis |
19782086 | This study evaluates whether carbamylated erythropoietin is as effective as recombinant human erythropoietin in protecting endothelial progenitor cells (EPCs) from apoptosis without stimulating erythropoiesis |
19782086 | In UT-7, carbamylated erythropoietin (C-darbe) induced phosphorylation of the anti-apoptotic Jak-2/Akt signal and, as opposed to recombinant human erythropoietin (darbe), did not produce a significant activation of cell proliferating signals |
18924487 | Produced in low/moderate concentrations as molecular signals that regulate a series of physiological processes, such as a defence against infectious agents, the maintenance of vascular tone, the control of ventilation and erythropoietin production, and signal transduction from membrane receptors in various physiological processes |
18466174 | The serum erythropoietin (sEPO) and hemoglobin (Hb) levels in peripheral blood were also determined |
17402563 | Finally, we found that erythropoietin is an ischemia-induced angiogenic factor that acts independently and as potently as VEGF in proliferative diabetic retinopathy (PDR) |
17188915 | A selective lysis of relatively young erythrocytes (neocytolysis), together with a decrease of erythropoietin (EPO) production, has been described in polycythemic, high altitude acclimatized climbers, after descent to sea level, and in astronauts, soon after exposure to weightlessness (Alfrey CP, Rice L, Udden MM, Driscoll TB |
17188915 | A selective lysis of relatively young erythrocytes (neocytolysis), together with a decrease of erythropoietin (EPO) production, has been described in polycythemic, high altitude acclimatized climbers, after descent to sea level, and in astronauts, soon after exposure to weightlessness (Alfrey CP, Rice L, Udden MM, Driscoll TB |
16827160 | In the immortalized HDFs, the transcriptional activity of HIF-1alpha was also evident by the accumulation of its main downstream gene targets, namely erythropoietin (EPO) and the vascular endothelial growth factor (VEGF) |
16827160 | In the immortalized HDFs, the transcriptional activity of HIF-1alpha was also evident by the accumulation of its main downstream gene targets, namely erythropoietin (EPO) and the vascular endothelial growth factor (VEGF) |
10869423 | In situ RNA hybridization revealed that renox is highly expressed at the site of erythropoietin production in the renal cortex, showing the greatest accumulation of renox mRNA in proximal convoluted tubule epithelial cells |
10027758 | Maze learning impairment is associated with stress hemopoiesis induced by chronic treatment of aged rats with human recombinant erythropoietin |
10027758 | We evaluated hematological changes in 21-mo old male Fischer 344 rats undergoing a 3-mo twice weekly subcutaneous injection of human recombinant erythropoietin (EPO) |
10027758 | We evaluated hematological changes in 21-mo old male Fischer 344 rats undergoing a 3-mo twice weekly subcutaneous injection of human recombinant erythropoietin (EPO) |
10027758 | A baseline hematocrit (HCT) was obtained initially and repeated at monthly intervals to determine the effectiveness of EPO treatment |
10027758 | At 24-mo of age and after 3 mo EPO treatment, the rats were tested for their ability to learn a 14-unit T maze |
10027758 | After 1 mo EPO treatment, HCT significantly increased compared to saline-injected controls |
10027758 | After 3 mo EPO treatment, MCV was significantly lower in EPO-treated rats compared to controls |
10027758 | The G, which measures the membrane contribution to deformability, very significantly increased with EPO treatment |
10027758 | This finding indicates an increased contribution of membrane properties to the MCTT after EPO treatment, which cancels the expected decrease in MCTT for smaller cells |
10027758 | After 3 mo of EPO treatment, aged rats exhibited significantly impaired maze learning compared to controls |
Entries Per Page
Displaying Page of